https://ipharmag.com/article/retatrutide-explained-research-peptide-risks iPharmag en 2026-09-28T01:55:20+00:00 Retatrutide Explained: What the Trials Show, and Why “Research Peptide” Versions Are Risky https://ipharmag.com/article/glucosamine-supplement-linked-faster-alzheimers-progression iPharmag en 2026-09-28T01:55:20+00:00 Glucosamine, a Popular Joint Supplement, Linked to Faster Alzheimer’s Progression https://ipharmag.com/article/crispr-ctx310-one-time-gene-edit-halves-ldl-cholesterol-year iPharmag en 2026-09-28T01:55:20+00:00 A One-Time CRISPR Treatment Cut “Bad” Cholesterol in Half — and It Held for a Year